Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) Debt / Equity

CASTLE BIOSCIENCES, INC. (CSTL) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 0.02.
  • 2026-03-31: Debt/Equity Ratio 0.02.
  • 2025-12-31: Debt/Equity Ratio 0.02.
  • 2025-09-30: Debt/Equity Ratio 0.02.

Complete source-backed debt/equity ratio history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-300.02
2026-03-310.02
2025-12-310.02
2025-09-300.02
2025-06-300.02
2025-03-310.02
2024-12-310.02
2024-09-300.02
2024-06-300.02
2024-03-310.02
2023-12-310
2020-12-310
2020-09-300.13
2020-06-300.16
2020-03-310.29
2019-12-310.3
2019-09-300.3
2019-06-30-0.49
2018-12-31-0.43

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-310.02
2024-12-310.02
2023-12-310
2020-12-310
2019-12-310.3
2018-12-31-0.43

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B